Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dore

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The International Journal on Drug Policy|August 28, 2021
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage studyA Conway, H Valerio, A Peacock, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaB Jacka, T Applegate, M Krajden, et al.
Journal of Viral Hepatitis|November 4, 2016
Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> StudyC Rodrigo, A A Eltahla, R A Bull, et al.
Journal of Viral Hepatitis|January 13, 2015
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 studyB Hajarizadeh, B Grady, K Page, et al.
Journal of Viral Hepatitis|September 27, 2016
Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continentsA A Eltahla, C Rodrigo, B Betz-Stablein, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The International Journal on Drug Policy|August 28, 2021
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage studyA Conway, H Valerio, A Peacock, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaB Jacka, T Applegate, M Krajden, et al.
Journal of Viral Hepatitis|November 4, 2016
Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> StudyC Rodrigo, A A Eltahla, R A Bull, et al.
Journal of Viral Hepatitis|January 13, 2015
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 studyB Hajarizadeh, B Grady, K Page, et al.
Journal of Viral Hepatitis|September 27, 2016
Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continentsA A Eltahla, C Rodrigo, B Betz-Stablein, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Pageof 7